Remarkable Results in the Treatment of Patients with Relapsed Large B-Cell Lymphoma
Directly from ASH21 we offer you an update from the ZUMA‑7 study, A Phase 3 Randomized Trial of Axi-Cel Treatment for patients with relapsed large B-Cell Lymphoma. The results are remarkable, Axi-Cel Treatment is one of the new treatments for lymphoma patients that will likely become a new paradigm in the future. In this MEDtalk Frederik L. Locke, sums up the background of the study and presents the convincing results.
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.